Carregant...
Mutant p53 in cancer therapy—the barrier or the path
Since wild-type p53 is central for maintaining genomic stability and preventing oncogenesis, its coding gene TP53 is highly mutated in ~50% of human cancers, and its activity is almost abrogated in the rest of cancers. Approximately 80% of p53 mutations are single point mutations with several hotspo...
Guardat en:
| Publicat a: | J Mol Cell Biol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487791/ https://ncbi.nlm.nih.gov/pubmed/30508182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjy072 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|